top of page
News, Events and Updates
Search
Anavex Comments on FDA Plan to Expedite Approval of New Alzheimer's Drugs
Mar 18, 2013
ANAVEX 2-73 Restores Mitochondrial Functionality, Clocks Cell Death and Oxidative Stress
Mar 12, 2013
Mitochondrial Protection in Mouse Hippocampus against Aβ25-35 Toxicity is Induced by the Novel...
Mar 6, 2013
Anavex Retains Novak Druce Connolly Bove & Quigg; Maximize Value of Intellectual Property Portfolio
Feb 4, 2013
Amyloid Toxicity Induced by Oligomeric Aβ25-35 Injection Enhanced after Pharmacologic or Genetic...
Jan 11, 2013
Implication of the σ1 Chaperone Protein in Adult Neurogenesis: Contribution to Neuroprotection?
Jan 11, 2013
Anavex Appoints Tom Skarpelos as Director
Jan 10, 2013
ANAVEX 2-73 Shown to Block Oxidative Stress, Preventing Onset of Alzheimer's Disease
Oct 18, 2012
Mitochondrial Protection is Induced by the Novel Tetrahydrofuran Derivative ANAVEX2-73 after ICV...
Oct 13, 2012
Anavex to Present at Neuroscience 2012 in New Orleans
Oct 12, 2012
Anavex Recognizes Alzheimer's Action Day
Sep 21, 2012
41
42
43
44
45
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
